CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 811 - 820 of 842
Study Number Lead Group Study Title CIRB Study Status
AOST1322 COG A Phase II Study of Eribulin (IND# 122686; NSC# 707389) in Recurrent or Refractory Osteosarcoma: An Intergroup NCTN Phase II Study Pediatric CIRB Completed
E1A00 ECOG A Randomized Phase III Trial of Thalidomide (NSC #66847) Plus Dexamethasone Versus Dexamethasone in Newly Diagnosed Multiple Myeloma Adult CIRB - Late Phase Emphasis Completed
S0200 SWOG A Phase III Randomized Study of Pegylated Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients with Recurrent Epithelial Ovarian or Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy Adult CIRB - Late Phase Emphasis Completed
AHOD04B1 COG Hodgkin Disease (HD) Banking Study Pediatric CIRB Completed
9571 ETCTN A phase IB study of the combination of AZD6244 hydrogen sulfate (selumetinib) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer Adult CIRB - Early Phase Emphasis Completed
ADVL0221 COG A Phase II Study of Trabectedin (ET-743; Yondelis) in Children with Recurrent Rhabdomyosarcoma; Ewing Sarcoma; or Nonrhabdomyosarcomatous Soft Tissue Sarcomas Pediatric CIRB Completed
E3201 ECOG Intergroup Randomized Phase III Study of Postoperative Irinotecan; 5-Fluorouracil and Leucovorin Vs Oxaliplatin; 5-Fluorouracil and Leucovorin Vs 5-Fluorouracil and Leucovorin For Patients with Stage II or III Rectal Cancer Receiving Either Preoperative Radiation and 5-Fluorouracil or Postoperative Radiation and 5-Fluorouracil Adult CIRB - Late Phase Emphasis Completed
AREN0321 COG Treatment of High Risk Renal Tumors: A Groupwide Phase II Study Pediatric CIRB Completed
NCIC-MA.27B NCIC CTG The Influence of Five Years of Adjuvant Anastrozole or Exemestane on bone Mineral Density in Postmenopausal Women with Primary Breast Cancer - A Companion Study to NCIC CTG MA.27 Adult CIRB - Late Phase Emphasis Completed
S0427 SWOG A Phase III Trial of Standard Fractionation Radiation and Concurrent Single Agent Cisplatin; with and without Docetaxel; Cisplatin; and 5-FluorouracilInduction Chemotherapy; in Patients with Advanced Oropharyngeal Squamous Cell Cancer Adult CIRB - Late Phase Emphasis Completed
Displaying 811 - 820 of 842